Manufacturers Of Albumin-Based Products Allowed To Use Plasma From UK Donors
Albumin medicinal products manufactured using plasma from UK donors pose minimal, if any, risk of infecting recipients with variant Creutzfeldt-Jakob disease, the UK regulator has determined.
You may also be interested in...
The European Commission’s proposals to overhaul the EU pharma legislation, which will see some orphan drug incentives cut, would cause a “significant dip in innovation,” according to number crunching from pharma industry association EFPIA.
Governments should increase financial resources for novel antimicrobial drug candidates in the later stages of development and tackle shortages of existing, underused antibiotics to combat antimicrobial resistance, says a new report from the OECD.
A report published by the European Medicines Agency highlights milestones reached under its collaboration with EUnetHTA over recent years and outlines areas for further development once the initiative changes hands under the new HTA Regulation.